1.
|
Phase: Phase IV Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: DTC-96-001, NCI-V97-1337
|
|
2.
|
Phase: Phase IV Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: SKY0101-010, NCT00029523
|
|
3.
|
Phase: Phase III, Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: GMALL06, NCT00199108
|
|
4.
|
Phase: Phase III Type: Treatment Status: Closed Age: any age Sponsor: Pharmaceutical / Industry Protocol IDs: MSKCC-94129, NCI-V95-0661
|
|
5.
|
Phase: Phase III Type: Treatment Status: Closed Age: 3 and over Sponsor: Pharmaceutical / Industry Protocol IDs: DTC-92-001, NCI-V97-1338
|
|
6.
|
Phase: Phase II Type: Treatment Status: Closed Age: 6 mo. to under 21 at relapse Sponsor: NCI Protocol IDs: POG-9412, NCT00002704
|
|
7.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: CDR0000510918, U01CA070019, AMC-048, NCT00392834
|
|
8.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: 2004-004414-17, DEPOCYLAN, NCT00388531
|
|
9.
|
Phase: Phase II Type: Treatment Status: Temporarily closed Age: Less than 18 Sponsor: Other Protocol IDs: CILI, 2011-002622-48, NCT01593488
|
|
10.
|
Phase: Phase I Type: Treatment Status: Closed Age: 1 to 21 Sponsor: Pharmaceutical / Industry Protocol IDs: CDR0000065754, SKYEPHARMA-96-002, DTC-96-002, NCI-V97-1336, NCT00003073
|